Rating History for Cyteir Therapeutics (CYT) by Morgan Stanley
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 2/3/2023 | Jeffrey Hung | Downgrade | Underweight (Equalweight) |
2.00 (4.00) |
1.57 (3.02) |
92.36% | Details |
 |
|||||||
|
|||||||
